Tchaikapharma High Quality Medicines AD (BUL:THQM)
13.00
0.00 (0.00%)
At close: Feb 25, 2025
BUL:THQM Revenue
In the year 2024, Tchaikapharma High Quality Medicines AD had annual revenue of 53.14M BGN with 9.54% growth. Tchaikapharma High Quality Medicines AD had revenue of 12.73M in the quarter ending December 31, 2024, with 34.88% growth.
Revenue
53.14M
Revenue Growth
+9.54%
P/S Ratio
22.46
Revenue / Employee
256.72K
Employees
207
Market Cap
1.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 53.14M | 4.63M | 9.54% |
Dec 31, 2023 | 48.51M | 5.37M | 12.44% |
Dec 31, 2022 | 43.15M | 715.00K | 1.69% |
Dec 31, 2021 | 42.43M | 2.33M | 5.80% |
Dec 31, 2020 | 40.11M | 5.38M | 15.50% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shelly Group SE | 208.70M |
Speedy AD | 501.59M |
Sopharma AD | 2.15B |
First Investment Bank AD | 413.68M |
Eurohold Bulgaria AD | 2.64B |
M+S Hydraulic AD | 154.88M |
Holding Varna AD | 88.88M |
Smart Organic AD | 88.27M |